Physician profile
Leon Stern
NPI 1881747657
$4,510.51
in general payments reported to CMS, 2019-2025
17 companies · $1,795 in 2025
The $1,795 reported for 2025 was more than what 88% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,715 · 2025: $1,795.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,795.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $844.84 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $823.45 | 2019-2025 | Uzedy |
| Janssen Pharmaceuticals, INC | $552.07 | 2019-2025 | Invega Sustenna |
| Allergan, INC. | $489.56 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $424.14 | 2025 | Caplyta |
| Sunovion Pharmaceuticals INC. | $399.18 | 2019 | |
| Alkermes, INC. | $230.65 | 2019-2025 | Aristada, Aristada Initio, Lybalvi |
| Axsome Therapeutics, INC. | $191.51 | 2025 | Auvelity |
| E.R. Squibb & Sons, L.L.C. | $140.12 | 2025 | Cobenfy |
| Avanir Pharmaceuticals, INC. | $118.28 | 2019 | |
| Abbvie INC. | $95.25 | 2025 | |
| Vanda Pharmaceuticals INC. | $51.30 | 2025 | Hetlioz, Fanapt |
| Neuronetics, INC. | $43.50 | 2019 | |
| Lundbeck LLC | $41.91 | 2019 | |
| Indivior INC. | $25.09 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $21.33 | 2019 | |
| Bausch Health US, LLC | $18.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leon Stern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.